PRECIGEN, INC. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Precigen, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q1 2024.
  • Precigen, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$29K, a 47.3% increase year-over-year.
  • Precigen, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$479K, a 219% decline from 2022.
  • Precigen, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$150K, a 10.2% increase from 2021.
  • Precigen, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$167K, a 7.05% decline from 2020.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$29K +$26K +47.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 -$55K +$3K +5.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 -$58K -$2K -3.57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 -$56K -$56K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 -$3.17M $0 +$508K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$3.67M -$2.23M -$283K -14.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$3.39M -$467K +$13.8M +96.7% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$17.2M -$473K +$542K +53.4% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$17.7M -$508K +$3.57M +87.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$21.3M -$1.94M -$1.71M -730% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$19.6M -$14.2M -$13.5M -1738% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$6.1M -$1.02M -$134K -15.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$5.96M -$4.07M -$3.44M -539% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$2.53M -$234K +$266K +53.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$2.79M -$775K -$467K -152% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.33M -$881K -$410K -87% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$1.92M -$638K +$1.55M +70.8% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-08-13
Q4 2016 -$3.47M -$500K -$1.24M -167% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$2.22M -$308K +$270K +46.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$2.49M -$471K -$628K -400% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$1.87M -$2.19M -$2.98M -375% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.12M $743K +$743K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $374K -$578K -$578K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $952K $157K +$157K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $795K $795K +$795K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.